Crystal structure of resmetirom heminonahydrate Form CSI, C 17 H 12 Cl 2 N 6 O 4 (H 2 O) 4
Source abstract
Abstract
Abstract The crystal structure of resmetirom heminonahydrate Form CSI has been solved and refined using synchrotron X-ray powder diffraction data and optimized using density functional theory techniques. Form CSI had been described previously as a dihydrate. Resmetirom heminonahydrate Form CSI crystallizes in space group P-1 (#2) with a = 11.3094(23), b = 15.158(6), c = 16.570(7) Å, α = 67.405(13), β = 74.425(7), γ = 69.526(7)°, V = 2,427.2(4) Å 3 , and Z = 4 at 298 K. The crystal structure consists of layers of resmetirom molecules parallel to the bc -plane. These layers are separated by water-rich layers also parallel to the bc -plane. A strong N–H···O links the two resmetirom molecules. The equivalent amino group in the other molecule acts as a donor to a water molecule. A number of C–H···O and C–H···N hydrogen bonds also contribute to the lattice energy. Water molecules act as donors to both O and N in the resmetirom molecules. The structure is more complicated than a hydrogen-bonded framework of resmetirom molecules with water in the pores. The powder pattern has been submitted to the International Centre for Diffraction Data (ICDD) for inclusion in the Powder Diffraction File ™ (PDF ® ).
Source: crossref · Quality: baseline
Research context
OpenAlex topics: X-ray Diffraction in Crystallography · Microwave-Assisted Synthesis and Applications · Pigment Synthesis and Properties
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Illinois Institute of Technology
North Central College
International Centre for Diffraction Data (ICDD)
Funding
International Centre for Diffraction Data
References (30)
Show source-provided references
1. 10.1107/S205252061800233010.1107/S2052520618002330 ↗
2. 10.3406/bulmi.1907.282010.3406/bulmi.1907.2820 ↗
3. 2024
4. Chen, M. , and Chang, X. . 2021. “Resmetirom Crystal Form and Preparation Method Therefor and Use Thereof.” International Patent Application WO 2021/063367 A1.
5. 10.1002/jcc.2315310.1002/jcc.23153 ↗
6. Hester, D. K. , Duguid, R. J. , Kelly, M. J. , Chasnoff, A. , Dong, G. , Crow, E. L. , Choi, D. S. , Shu, L. , and Wang, P. . 2016. “Method of Synthesizing Thyroid Hormone Analogs and Polymorphs Thereof.” U.S. Patent 9266861 B2.
7. 10.1093/nar/gkac95610.1093/nar/gkac956 ↗
8. 10.1107/S002188981300353110.1107/S0021889813003531 ↗
9. 10.1021/acs.jctc.2c0095810.1021/acs.jctc.2c00958 ↗
10. 2023
11. 10.1017/S088571561400051710.1017/S0885715614000517 ↗
12. 2013
13. 10.1017/S088571561800082910.1017/S0885715618000829 ↗
14. 10.1107/S002188981301311310.1107/S0021889813013113 ↗
15. 2025
16. Bravais · 1866
17. 10.1107/S205252061600395410.1107/S2052520616003954 ↗
18. 10.1063/1.46788210.1063/1.467882 ↗
19. 2024
20. A New Law of Crystal Morphology Extending the Law of Bravais
21. 10.1107/S002188989800600110.1107/S0021889898006001 ↗
22. 10.1107/S002188981101462210.1107/S0021889811014622 ↗
23. 10.1016/0927-0256(96)00008-010.1016/0927-0256(96)00008-0 ↗
24. 10.1021/ci049780b10.1021/ci049780b ↗
25. Lapido, P. , Goldshtein, J. , Krimer, V. , and Rudik, D. . 2022. “Solid State Forms of Resmetirom.” International Patent Application WO 2022/086894 A1.
26. 10.1017/S088571562400015010.1017/S0885715624000150 ↗
27. 10.1107/S160057752100249610.1107/S1600577521002496 ↗
28. 2023
29. 10.1107/S205252061402290210.1107/S2052520614022902 ↗
30. 10.1107/S160057671901409210.1107/S1600576719014092 ↗